NYSE:HYH - Halyard Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $57.25 +0.04 (+0.07 %) (As of 10/19/2018 04:00 PM ET)Previous Close$57.25Today's Range$56.93 - $57.9152-Week Range$38.22 - $61.52Volume886,271 shsAverage Volume438,537 shsMarket Capitalization$2.69 billionP/E Ratio24.36Dividend YieldN/ABeta1.67 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Receive HYH News and Ratings via Email Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical SymbolNYSE:HYH CUSIPN/A Webwww.halyardhealth.com Phone678-425-9273 Debt Debt-to-Equity Ratio0.43 Current Ratio3.22 Quick Ratio2.96 Price-To-Earnings Trailing P/E Ratio24.36 Forward P/E Ratio32.71 P/E Growth3.68 Sales & Book Value Annual Sales$611.60 million Price / Sales4.40 Cash Flow$1.2427 per share Price / Cash46.07 Book Value$25.95 per share Price / Book2.21 Profitability EPS (Most Recent Fiscal Year)$2.35 Net Income$79.30 million Net Margins7.72% Return on Equity7.90% Return on Assets4.38% Miscellaneous Employees13,000 Outstanding Shares47,020,000Market Cap$2.69 billion Halyard Health (NYSE:HYH) Frequently Asked Questions What is Halyard Health's stock symbol? Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH." How were Halyard Health's earnings last quarter? Halyard Health (NYSE:HYH) issued its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.47 by $0.13. The medical instruments supplier had revenue of $401.40 million for the quarter, compared to analysts' expectations of $394.54 million. Halyard Health had a net margin of 7.72% and a return on equity of 7.90%. The company's revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.48 EPS. View Halyard Health's Earnings History. What price target have analysts set for HYH? 4 brokerages have issued twelve-month target prices for Halyard Health's shares. Their predictions range from $50.00 to $67.00. On average, they expect Halyard Health's share price to reach $59.25 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Price Targets for Halyard Health. What is the consensus analysts' recommendation for Halyard Health? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halyard Health in the last year. There are currently 1 sell rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Halyard Health. Who are some of Halyard Health's key competitors? Some companies that are related to Halyard Health include Steris (STE), WILLIAM DEMANT/ADR (WILYY), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Sientra (SIEN), Establishment Labs (ESTA), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Rewalk Robotics (RWLK), Histogenics (HSGX) and COLLPLANT HOLDI/S (CLGN). Who are Halyard Health's key executives? Halyard Health's management team includes the folowing people: Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)Mr. Joseph F. Woody, CEO & Director (Age 52)Mr. Renato Negro, VP, Controller & Chief Accounting Officer How do I buy shares of Halyard Health? Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Halyard Health's stock price today? One share of HYH stock can currently be purchased for approximately $57.25. How big of a company is Halyard Health? Halyard Health has a market capitalization of $2.69 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe. What is Halyard Health's official website? The official website for Halyard Health is http://www.halyardhealth.com. How can I contact Halyard Health? Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected] MarketBeat Community Rating for Halyard Health (NYSE HYH)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 221 (Vote Outperform)Underperform Votes: 230 (Vote Underperform)Total Votes: 451MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/20/2018 by MarketBeat.com StaffFeatured Article: Why is the ex-dividend date different from the record date?